Search Results
Onco
Daily
Facebook
RSS
X
Youtube
Linkedin
October, 2024
October 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Sep
Breast Cancer
Oct 14, 2024, 18:23 |
Blog
Erika Hamilton on WKRN News 2 about common myths about breast cancer
Erika Hamilton shared a post on LinkedIn: "Happy to talk to Blake Eason this morning on…
Oct 14, 2024, 13:02 |
Insight
Paper Alert ! Use of Antibody–Drug Conjugates in the Early Setting of Breast Cancer
Use of Antibody–Drug Conjugates in the Early Setting of Breast Cancer Authors: Chrysanthi Koukoutzeli, Dario…
Oct 14, 2024, 11:50 |
Blog
Sally Wolf: Pure pink doesn't include metastatic breast cancer
Sally Wolf, CEO and Founder, LightWorks, shared a post on LinkedIn: "If you loved the…
Oct 13, 2024, 10:49 |
Blog
Arya Roy: The effectiveness and toxicity of Sacituzumab Govitecan in Metastatic Triple-Negative Breast Cancer
Arya Roy shared a post on X: "Excited to share our study on the effectiveness &…
Oct 12, 2024, 15:47 |
Celebrities
Edie Falco and Breast Cancer: How She Went Against, How She Survived, and More
Edie Falco is a renowned American actress best known for her role as Carmela Soprano…
Oct 12, 2024, 12:44 |
Blog
Dukutober - a trademark of Breast Health Awareness Initiative of the Zambian Cancer Society
Zambian Cancer Society shared a post on LinkedIn: "Thank you our "Duku Dude" aka Silver Fox…
Oct 12, 2024, 11:21 |
Insight
How to determine optimal treatment for de novo metastatic breast cancer
Fumiko Ladd Chino shared a post on X: "Dr Jennifer Plichta, Duke Cancer Breast Surgical Oncology…
Oct 12, 2024, 10:30 |
Insight
FDA Approves Inavolisib with Palbociclib and Fulvestrant for Advanced Breast Cancer
On October 10, 2024, the FDA approved inavolisib (Itovebi, Genentech, Inc.) in combination with palbociclib…
Oct 11, 2024, 20:48 |
Blog
Benda Kithaka: Patient Navigation for the Early Detection, Diagnosis, Treatment of Breast Cancer
Benda Kithaka, Executive Director and Founder of KILELE Health Association, shared a post on LinkedIn:…
Oct 11, 2024, 19:57 |
Insight
Komal Jhaveri: Inavolisib approval for PIK3CA mutant ER+ metastatic breast cancer
Komal Jhaveri, Clinical Director of the Early Drug Development Service at Memorial Sloan Kettering Cancer…
51
52
53
54
55
All:
2721
Posts:
521 - 530
Dikembe Mutombo: In Memory of Basketball Icon Who Died at 58 Battling Brain Cancer
100 Influential Women in Oncology: Key Opinion Leaders to Follow on Social Media in 2024: Part 7
ESTRO: Everything You Need to Know About European Society for Radiotherapy and Oncology
Jane Fonda Breast Cancer and Non-Hodgkin Lymphoma: How She Went Against, How She Survived, and More
Inside OncoDaily Party Barcelona
Special Coverage
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Facebook
RSS Feed
X
Linkedin
Youtube